A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients
Keywords:
Materias Investigacion::Ciencias de la Salud::Oncología
Acute myeloid leukemia
Ex vivo assay
Pharmacological profile
Complete remission
Clinical correlation
Note:
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Citation:
Martínez-Cuadron, D. (David); Gil, C. (Cristina); Serrano, J. (Josefina); et al. "A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients". Leukemia Research. 76, 2019, 1 - 10
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.